MedTrace Logo

ExoAtlet II For SCI Patients

NCT04215081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-07-27

No results posted yet for this study

Summary

This study will evaluate the ExoAtlet II exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, to stand up and ambulate under a variety of conditions.

Conditions

  • Spinal Cord Injuries
  • Paraplegia

Interventions

DEVICE

Gait training using ExoAtlet exoskeleton

Subjects will learn to use the ExoAtlet II exoskeleton, with the assistance of a trained medical professional, to perform functional activities (including stand-up, sit-down, stepping forward, and walking).

Sponsors & Collaborators

  • COSMO ROBOTICS CO., Ltd

    lead INDUSTRY

Principal Investigators

  • Sergey Kotov, MD · Moscow Regional Research and Clinical Institute (MONIKI)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-18
Primary Completion
2020-01-04
Completion
2020-01-04

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215081 on ClinicalTrials.gov